Peptilogics: Funding, Investors & Team (Oct 2026)
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
Peptilogics has raised $114M across 3 funding rounds on record, the most recent a Series B of $78.0M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Peptilogics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Peptilogics Funding Rounds
Peptilogics raised $35.4M in an undisclosed round announced in Dec 2020.
1.1 years later, a Grant of $100k was announced in Jan 2022.
3.8 years later, a Series B of $78.0M was announced in Oct 2025.
Peptilogics Founders and Leadership Team
Contact details for the Peptilogics team: 2 of 3 have an email address on file.
Start 14-day free trial →Peptilogics Funding Compared to Other Biotechnology Startups
Peptilogics' latest round of $78.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Peptilogics in Biotechnology and Pittsburgh
Companies Similar to Peptilogics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Peptilogics Funding FAQs
What does Peptilogics do?
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
How much funding has Peptilogics raised?
Peptilogics has raised $114M across 3 rounds on record. The most recent is a Series B of $78.0M announced in Oct 2025.
When did Peptilogics last raise funding?
Peptilogics' most recent funding round on record is a Series B of $78.0M, announced in Oct 2025.
Who founded Peptilogics?
FundedIQ lists Ron Montelaro (Founder) at Peptilogics.
Who is the CEO of Peptilogics?
Jonathan Steckbeck is listed as CEO at Peptilogics.
Where is Peptilogics headquartered?
Peptilogics is based in Pittsburgh, Pennsylvania, United States.
How many employees does Peptilogics have?
Peptilogics is in the 11-50 employee band.
How does Peptilogics' funding compare to other Biotechnology startups?
Peptilogics' latest round of $78.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Peptilogics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Peptilogics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.